Long‐term sequential deferiprone and deferasirox therapy in transfusion‐dependent thalassaemia patients: a prospective clinical trial
Open Access
- 25 July 2019
- journal article
- letter
- Published by Wiley in British Journal of Haematology
- Vol. 186 (6) , E209-E211
Abstract
No abstract availableKeywords
This publication has 3 references indexed in Scilit:
- The era of comparable life expectancy between thalassaemia major and intermedia: Is it time to revisit the major‐intermedia dichotomy?British Journal of Haematology, 2016
- A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemiaBlood, 2006
- Randomized controlled trial of deferiprone or deferoxamine in beta-thalassemia major patients with asymptomatic myocardial siderosisBlood, 2006